Analytical Data
-
基因名
RPS6
- Application
-
别名
Phosphoprotein NP33 （Small ribosomal subunit protein eS6）
-
种属
Human
-
表达系统
E. coli
-
标签
N- His-GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P62753
-
表达区间
35-229aa
-
分子量
53.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RPS6, or Ribosomal Protein S6, is a crucial component of the ribosome that plays a significant role in protein synthesis and cellular growth. It is a key player in the regulation of translation and is heavily involved in the response to growth factors and hormones. Dysregulation of RPS6 has been implicated in various diseases, including cancer, as it is associated with the signaling pathways of mTOR (mammalian Target of Rapamycin), which regulates cell growth and metabolism. The study of RPS6 recombinant proteins has gained momentum in recent years due to the potential therapeutic implications of targeting RPS6 in disease contexts. By producing RPS6 as a recombinant protein, researchers can investigate its structural and functional properties, enabling a deeper understanding of its role in translation regulation. Furthermore, studying RPS6 in its recombinant form allows for the exploration of post-translational modifications and protein interactions that are critical for its activity. This research holds promise for developing novel therapeutic strategies aimed at modulating protein synthesis in disease states, particularly in cancers where RPS6 activity is often aberrant. Through these studies, scientists hope to delineate the specific functions of RPS6 and its potential as a biomarker or therapeutic target in disease management.
